Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
(Q37613320)
scientific article published on 27 July 2015
scientific article published on 27 July 2015
Language:
Current Data About
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
other details
description | scientific article published on 27 July 2015 |
External Links
(P356) |
10.1111/BJH.13603
|
(P698) |
26213141
|
(P932) |
5278973
|
(P8608) |
release_x2244d46svekbeg4rxmiqwk54i
|